{"created":"2023-07-27T06:59:59.138198+00:00","id":59753,"links":{},"metadata":{"_buckets":{"deposit":"be908364-44b7-4128-bed3-30190f05b189"},"_deposit":{"created_by":18,"id":"59753","owners":[18],"pid":{"revision_id":0,"type":"depid","value":"59753"},"status":"published"},"_oai":{"id":"oai:kanazawa-u.repo.nii.ac.jp:00059753","sets":["2812:2813:2835"]},"author_link":["21362","105344"],"item_9_biblio_info_8":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"1999-12-07","bibliographicIssueDateType":"Issued"},"bibliographicPageStart":"3p.","bibliographicVolumeNumber":"1997 – 1998","bibliographic_titles":[{"bibliographic_title":"平成10(1998)年度 科学研究費補助金 基盤研究(C) 研究成果報告書概要"},{"bibliographic_title":"1998 Fiscal Year Final Research Report Summary","bibliographic_titleLang":"en"}]}]},"item_9_creator_33":{"attribute_name":"著者別表示","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{}],"nameIdentifiers":[{},{},{}]}]},"item_9_description_21":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"ラット自然発症慢性膵炎モデル(WBN/Kob)では12週令から慢性膵炎の変化が起こり,週令とともに顕著になった.RT-PCR法による膵組織中pancreatitis-associated-protein(PAP)mRNAの発現動態の検討では,膵炎発症前の8週令から上昇し,12週令でピークに達し,24週令でほとんど消失した.PAPが膵腺房細胞に発現することをmRNAレベルではin situ hybridization法,蛋白レベルでは免疫染色法により確認した.膵炎治療薬(メシル酸カモスタット,柴胡桂枝湯)投与により,膵炎の発症と進展が抑制され,PAPmRNA発現も低下した.アポトーシスの検討では,膵内炎症細胞にアポトーシス陽性細胞が認められたが,膵腺房細胞にはほとんど検出されなかった.膵腺房培養細胞を用いたin vitroの系で,PAPのアポトーシス抑制作用を見い出し,現在さらに検討中である.臨床的には,196例の消化器疾患において血清PAP値をELISA法により測定したところ,その陽性率は急性膵炎で90%であり,膵炎の重症度と有意に関連し,その上昇は他の膵酵素に比し遷延し,急性膵炎の治癒に一致して正常化した.また,各種消化器癌での血清PAPの陽性率は,胃癌16%,大腸癌40%,肝細胞癌40%,胆道癌26%,膵癌40%であった.以上より,慢性膵炎の発症と進展にPAPの発現が関連し,その意義としてアポトーシス抑制作用が考えられた.また,血清PAP値が膵炎の重症度や治癒判定の指標になること,癌細胞での異所性発現を反映して消化器癌の一部でも血清PAP値が上昇することを明らかにした.","subitem_description_type":"Abstract"},{"subitem_description":"In spontaneous chronic pancreatitis model (WBN/Kob rats), pancreatitis was first observed at 12 weeks, and progressed thereafter. By the analysis with RT-PCR, PAP mRNA started to be expressed at 8 weeks, peaked at 12 weeks, and then almost disappeard at 24 weeks. PAP was expressed in the cytoplasm of pancreatic acinar cells by the analysis with in situ hybridization and immunohistochemistry. Expression of cytokines such as TNF-alpha and IL-6 was also studied. TNF-alpha and IL-6 peaked at 8 and 12 weeks, respectively. Drug therapy (camostat mesilate and Saiko-keishi-to) prevented the development of pancreatitis and suppressed the gene expression of PAP and cytokines.\nAs for apoptosis, the TUNEL method revealed abundant apoptotic inflammatory cells in the stroma of the pancreata of WBN/Kob rats at 12 weeks. However, only a few apoptotic cells were detected in the acini. Anti-apoptotic effets of PAP were suggested in in vitro system using a rat pancreatic acinar AR42J cell line treated with L-arginine.\nClinical studies on serum PAP in 196 patients with digestive diseases showed that serum PAP was increased in 90% cases of acute pancreatitis, which was significantly higher than the positive rate of 9% in clinically stable chronic pancreatitis. Serum PAP levels were significantly related to the severity of pancreatitis. The elevation of serum PAP prolonged compared to other pancreatic enzymes or CRP, and serum PAP was normalized at the time of clinical healing of acute pancreatitis. The positive rates of serum PAP in gastrointestinal cancers were as follows : gastric cancer 16%, colorectal cancer 40%, hepatocellular carcinoma 40%, biliary tract cancer 26% and pancreatic cancer 40%. Serum PAP was normalized after curative resection of the tumor in 7 cases.\nThese results suggest that PAP expression is related to the development and progression of chronic pancreatitis and that the action mechanisms of PAP include anti-apoptotic effects. Clinical studies implicate that serum PAP is a useful marker of the severity and healing of acute pancreatitis and that serum PAP is elevated in in cancer cells.","subitem_description_type":"Abstract"}]},"item_9_description_22":{"attribute_name":"内容記述","attribute_value_mlt":[{"subitem_description":"研究課題/領域番号:09670523, 研究期間(年度):1997 – 1998","subitem_description_type":"Other"},{"subitem_description":"出典：研究課題「慢性膵炎における膵炎関連蛋白の発現とアポトーシスの意義に関する実験的・臨床的研究 」課題番号09670523\n（KAKEN：科学研究費助成事業データベース（国立情報学研究所）） \n（https://kaken.nii.ac.jp/ja/report/KAKENHI-PROJECT-09670523/096705231998kenkyu_seika_hokoku_gaiyo/）を加工して作成","subitem_description_type":"Other"}]},"item_9_description_5":{"attribute_name":"提供者所属","attribute_value_mlt":[{"subitem_description":"金沢大学がん研究所","subitem_description_type":"Other"}]},"item_9_identifier_registration":{"attribute_name":"ID登録","attribute_value_mlt":[{"subitem_identifier_reg_text":"10.24517/00066008","subitem_identifier_reg_type":"JaLC"}]},"item_9_relation_28":{"attribute_name":"関連URI","attribute_value_mlt":[{"subitem_relation_name":[{"subitem_relation_name_text":"https://kaken.nii.ac.jp/search/?qm=80210095"}],"subitem_relation_type_id":{"subitem_relation_type_id_text":"https://kaken.nii.ac.jp/search/?qm=80210095","subitem_relation_type_select":"URI"}},{"subitem_relation_name":[{"subitem_relation_name_text":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-09670523/"}],"subitem_relation_type_id":{"subitem_relation_type_id_text":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-09670523/","subitem_relation_type_select":"URI"}},{"subitem_relation_name":[{"subitem_relation_name_text":"https://kaken.nii.ac.jp/ja/report/KAKENHI-PROJECT-09670523/096705231998kenkyu_seika_hokoku_gaiyo/"}],"subitem_relation_type_id":{"subitem_relation_type_id_text":"https://kaken.nii.ac.jp/ja/report/KAKENHI-PROJECT-09670523/096705231998kenkyu_seika_hokoku_gaiyo/","subitem_relation_type_select":"URI"}}]},"item_9_version_type_25":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_ab4af688f83e57aa","subitem_version_type":"AM"}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2022-05-27"}],"displaytype":"detail","filename":"CA-PR-MOTOO-Y-kaken 1999-3p.pdf","filesize":[{"value":"111.9 kB"}],"format":"application/pdf","licensetype":"license_11","mimetype":"application/pdf","url":{"label":"CA-PR-MOTOO-Y-kaken 1999-3p.pdf","url":"https://kanazawa-u.repo.nii.ac.jp/record/59753/files/CA-PR-MOTOO-Y-kaken 1999-3p.pdf"},"version_id":"9ffff7da-5879-4215-907c-aa8f46487cf4"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"research report","resourceuri":"http://purl.org/coar/resource_type/c_18ws"}]},"item_title":"慢性膵炎における膵炎関連蛋白の発現とアポトーシスの意義に関する実験的・臨床的研究","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"慢性膵炎における膵炎関連蛋白の発現とアポトーシスの意義に関する実験的・臨床的研究"},{"subitem_title":"Pancreatitis-associated protein and apoptocis in chronic pancreatitis","subitem_title_language":"en"}]},"item_type_id":"9","owner":"18","path":["2835"],"pubdate":{"attribute_name":"公開日","attribute_value":"2022-05-27"},"publish_date":"2022-05-27","publish_status":"0","recid":"59753","relation_version_is_last":true,"title":["慢性膵炎における膵炎関連蛋白の発現とアポトーシスの意義に関する実験的・臨床的研究"],"weko_creator_id":"18","weko_shared_id":-1},"updated":"2023-07-27T13:00:32.665165+00:00"}